Cerebellopontine Angle Tumours

What is this condition?

The cerebellopontine angle is a compact space beside the brainstem containing nerves for hearing, balance, facial movement and facial sensation. The commonest tumour is vestibular schwannoma (acoustic neuroma), but meningioma, epidermoid and other lesions also occur. Treatment must balance tumour control against preservation of hearing, facial movement and brainstem function.

What symptoms can it cause?

• One-sided hearing loss, tinnitus or difficulty understanding speech
• Imbalance, unsteadiness or vertigo
• Facial numbness, pain or weakness
• Large tumours may cause headache, swallowing problems, hydrocephalus or limb weakness

How is it assessed and diagnosed?

MRI of the internal auditory canals with contrast is the key test. Formal audiometry documents usable hearing. Vestibular tests, facial-nerve assessment and CT of the temporal bone may assist planning. Previous scans are particularly useful for measuring growth.

Treatment without surgery

Small stable tumours, particularly in older patients or those with limited symptoms, may be monitored. Hearing rehabilitation, balance therapy and symptom control may be needed. Radiosurgery can control growth of selected small-to-medium tumours but does not remove the mass immediately.

When is surgery or a procedure considered?

Microsurgery is considered for large size, brainstem pressure, hydrocephalus, growth, disabling symptoms or anatomy unsuitable for radiation. Retrosigmoid, translabyrinthine and selected middle-fossa routes have different hearing implications. Sometimes planned subtotal removal protects an adherent facial nerve, followed by surveillance or radiosurgery.

Treatment and procedure options

• Observation with MRI and hearing tests
• Microsurgery using an approach selected for size, anatomy and hearing
• Stereotactic radiosurgery for selected tumours
• Combined limited surgery and later radiosurgery

Risks from the disease and from treatment

Progressive tumours can permanently damage hearing or facial function and eventually compress the brainstem or block CSF. Treatment itself can also affect hearing, facial movement, swallowing, balance and CSF containment; the trade-off should be explicit. No procedure is risk-free. General risks include anaesthetic problems, bleeding, infection, blood clots and delayed healing. Neurological risks depend strongly on the exact structure being treated and may include new weakness, numbness, speech or vision change, seizure, cerebrospinal-fluid leakage, need for another procedure or failure to obtain the hoped-for relief. The surgeon should discuss the risks that apply to the individual case.

Recovery and follow-up

Early recovery often includes dizziness and fatigue. Facial function, eye closure and swallowing are checked carefully. Hearing outcome depends on starting hearing, tumour size and approach. Long-term MRI remains necessary after observation, radiation or incomplete removal. Recovery is not judged only by the first few days. Pain control, wound care, nutrition, safe mobilisation, physiotherapy and planned follow-up all matter. Some symptoms improve quickly after pressure is relieved; others recover gradually over weeks or months, and permanent nerve injury may not fully reverse.

Preparing for your consultation

Bring the original MRI/CT images or digital files, written reports, previous prescriptions, a current medicine list, and any operative or pathology records. For sudden warning symptoms, use the nearest emergency department rather than waiting for a routine appointment.

Authoritative patient-information sources

• NHS — Acoustic Neuroma: https://www.nhs.uk/conditions/acoustic-neuroma/
• AANS — Stereotactic Radiosurgery: https://www.aans.org/patients/conditions-treatments/stereotactic-radiosurgery/